The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
Journal Information
Full Title: Neuroscience
Abbreviation: Neuroscience
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosures L.B. is an employee and stockholder of Biogen Idec, Inc., which holds patents and pending patent applications in the United States and abroad on TWEAK-related molecules, including U.S. Patent No. 7129061, 7109298, 7087725, 7695934, 7566769, and 8048422."
Funding Disclosure
Evidence found in paper:
"This work was supported by the Wellcome Trust WT080782MF. We are grateful to the staff of the Medical Research Facility for their help with animal care."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025